"Heart" breakthrough!Kaide's cardiovascular team involved in completing the perfurate
Author:Zhuzhou Legal system Time:2022.06.13
Recently, the cardiovascular team of Cardiovascular Vascular Hospital of Zhuzhou Kaide applied the aortic valve replacement (TAVR surgery) for a patient with a patient who had undergone the destruction of the biological flap after the thoracic valve was prescribed. Realize a new breakthrough in heart disease treatment in Zhuzhou area, and set new hope for patients with severe heart disease.
Surgery site
Team photo
Half a month ago, nearly 70 -year -old Tang Yan (pseudonym) dragged his legs that had been swollen and could not walk, and accompanied the family to Zhuzhou Kaide Cardiovascular Vascular Hospital for cardiovascular surgery for help. It turned out that he had performed aortic valve and mitral valve replacement surgery 5 years ago due to cardiac valve disease. It is clear that the artificial biological valve was damaged by the previous surgery replacement, which means that the "door" of the heart is broken again. If you want to solve this problem, you need to replace this "door" again. However, this made Tang Yan and his family who did not want to go through the chest replacement of the heart valve surgery. After many inquiries of the family, the family decided to go to Zhuzhou Kaide Cardiovascular Vascular Hospital for minimally invasive treatment.
The patient's condition has received great attention from the hospital. Under the overall arrangement of the Ministry of Medical Affairs, the director of the hospital's heart center Liu Yu led, the deputy director of the cardiovascular surgery Xue Xiangsu and the cardiovascular department, the duct room, the surgical anesthesiology department, the intensive medical department, the ultrasound medical department , Double source CT and other professional teams have repeatedly discussed the condition of the patient's condition. After meticulous imaging evaluation and preoperative discussion, the current surgical method suitable for the patient is to use the catheter aortic valve replacement (TAVR surgery) to perform minimally invasive replacement changes Valve surgery, that is, the perfuration of the petals is placed in surgery. The surgical method is through the femoral arteries. The artificial heart valve is transmitted to the aortic valve area with an interventional catheter to replace the original aortic valve and realizes the normal physiological function of the valve. It is understood that in the past, these secondary or again heart surgery can only be completed in the country with a small number of three hospitals in China, but Tang Yan's condition can no longer bear the long distance. Adhering to the patient -centric principle, the hospital is in the hospital. With the trust and support of patients and family members, the operation was decided to perform the operation.
Under the guidance of the Xiangya Second Hospital experts, the MDT team of Cardiovascular Diseases successfully put a artificial heart valve in a small incision of only 3cm during the operation, replacing the diseased valve to start working, and the heart function returned to normal. Hope. After the surgery, under the guardianship of the severe medical department and cardiovascular surgery team, the day after Tang Yi's surgery, the symptoms were apparently relieved. You can get out of bed the next day.
Patient's recovery of hospital photo
Zhuzhou Kaide Cardiovascular Hospital has cardiovascular department, cardiovascular surgery, chest pain center, heart failure center, hypertension standard center, atrial fibrillation center, cardiac rehabilitation center, etc. Clinical key specialty, cardiovascular surgery is a provincial key clinical construction specialty. The hospital is a member of the medical education and research alliance of Peking University International Hospital.
- END -
"Health Hall" today broadcasts "The Black Technology of" Reverse "Intestinal Cancer"
expert:Yao Hongwei, Chief Physician of the Chief Physician of the Gastrointestinal...
The National Health and Health Commission issued the "Guidelines for the Diagnosis and Treatment of Children's Severe Acute Hepatitis (Trial)"
Since March 2022, many countries and regions around the world have reported unknow...